Advances in Anticoagulation: New Agents and Management Paradigms
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, January 15, 2009
First Floor Lecture Hall, Forchheimer/Einstein
Cherkasky Auditorium/Montefiore Medical Center
Kenneth A. Bauer, MD
Professor of Medicine, Harvard Medical School
Chief, Hematology Section, VA Boston Healthcare System
Director, Thrombosis Clinical Research, Beth Israel Deaconess Medical Center
Dr. Kenneth Bauer received his medical degree from Stanford University School of Medicine in Stanford, California. He completed his residency in medicine at the University of Chicago Hospitals and Clinics in Illinois. He was a Fellow in Medical Oncology and a Clinical/Research Fellow in the Division of Thrombosis and Hemostasis at Dana Farber Cancer Institute and was also a Clinical/Research Fellow in the Hematology-Oncology Division at Beth Israel Deaconess Medical Center.
Dr. Bauer’s research interests include development and clinical evaluation of sensitive assays for the detection of hypercoagulable states, definition and elucidation of the mechanisms leading to the development of a prethrombotic state, and clinical evaluation of new antithrombotic drugs.
Dr. Bauer previously served as Chairman of Council of the International Society on Thrombosis and Haemostasis (ISTH) and was Chairman of the Subcommittee on Predictive Haemostatic Variables in Vascular Diseases of the ISTH. He is Vice-President and Scientific Program Chair (Clinical) for the XXIInd ISTH Congress to be held in Boston in July 2009.
Dr. Bauer has published over 200 original reports, reviews, and book chapters.
Medical Grand Rounds this week is sponsored by the Division of Hematology.
After attending this activity, participants will be able to:
Review current indications and guidelines for anticoagulants, including prevention and treatment of venous thromboembolism and stroke prevention in patients with atrial fibrillation
Compare and contrast the mechanisms and distinguishing characteristics of available and emerging oral anticoagulants
Describe potential impact of new oral anticoagulants on patient management
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.